CLDF Title
Home | Contact Us | Bookmark
HBV HCC HCV HE NASH PBC
About CLDF Centers of Educational Expertise  
Webcasts Slide Library Abstract Library Conference Highlights
 

HCC | WEBCASTS

Beginning Date

7/10/2017

Ending Date

7/10/2018

1.25

credits

1.25

contact hours

Speakers

Catherine Frenette, MD
Medical Director of Liver Transplantation
Director, Hepatocellular Carcinoma Program
Scripps Center for Organ Transplantation
La Jolla, CA

Anshuman Bansal, MD
Interventional Radiology
Scripps Clinic
La Jolla, CA

Richard S. Finn, MD
Associate Professor of Medicine
Department of Medicine
Geffen School of Medicine at UCLA
Los Angeles, CA

Nicholas Nissen, MD
Director, Liver Transplantation and
Hepatopancreatobiliary Surgery Cedars-Sinai Medical Center
Los Angeles, CA

Webcasts

All webcasts must be viewed in their entirety to claim credit.

Introduction


Case 1: Resection


Case 2: Ablation


Case 3: Transarterial chemoembolization


Case 4: Sorafenib treatment

Certified by:

This activity is provided by the Chronic Liver Disease Foundation.

This activity Supported by:

AbbVie, Bristol-Myers Squibb and Salix.

Target Audience
This educational program will address the educational needs of health care professionals who manage patients with hepatocellular carcinoma and wish to improve standard practice of care.
 
Educational Objectives
At the conclusion of this activity, participants will be able to:
Review indications and contraindications for different locoregional and surgical therapies for HCC
Discuss the importance of multidisciplinary care of patients with hepatocellular carcinoma
 
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-17-074-H01-P. This program is designated for up to 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit.
 
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.

The opinions expressed during the enduring activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees' professional development.
 
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
 
Additional Planners/Reviewers affiliation and disclosure statements:
Catherine Frenette, MD
Consultant: Bayer, Conatus, Eisai
Speakers Bureau: Bristol-Myers Squibb, Gilead, Merck
Data Monitoring Board: Bayer, Gilead, Bristol-Myers Squibb, Salix, Intercept, Merck

Anshuman Bansal, MD
Employee: Scripps Clinic Medical Group

Richard S. Finn, MD
Consultant/Speaker Bureau: Bayer, Bristol-Myers Squibb, Eisai, Merck, Novartis, Pfizer

Nicholas Nissen, MD
No financial relationships to disclose.
 
 
 
                         
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.